INFORMATION FOR
News
The National Institutes of Health (NIH) recently awarded Yibing Qyang, PhD, and his colleagues a $2+ million R01 grant to support research to create an artificial blood vessel that can grow, pump, and resist infection and clotting.
The Heart Rhythm Society's annual meeting will feature the latest on atrial fibrillation, sudden cardiac arrest, ventricular arrhythmias, and more.
Connecticut Magazine's 2023 ‘Top Doctors’ list includes 16 faculty in the Section of Cardiovascular Medicine.
Fadi G. Akar, PhD, and Stuart Campbell, PhD, are the recipients of a $2.7M award for the project titled, “Desmoplakinopathies: Integrated Pathophysiology and Therapeutics.”
When untreated, patients with Chagas disease are at risk for arrhythmias, dilated cardiomyopathy, or heart failure.
In the United States, a significant number of patients continue to struggle with persistent hypertension.
Arya Mani, MD, outlined three recent discoveries from his lab.
Women’s symptoms, diagnoses, and even types of heart disease aren’t like men’s.
Groundbreaking clinical research at ACC 23.
Yale researchers have identified a potential target for the development of antihypertensive drugs.
Researchers have developed a tool to personalize the consideration for pursuing intensive versus standard blood pressure treatment goals.
A new study revealed several major differences. Men, for instance, tended to experience persistent atrial fibrillation. Women, on the other hand, were mostly paroxysmal, meaning they went in and out of atrial fibrillation and were often more symptomatic.
Matthew M. Burg, PhD, professor at the Yale School of Medicine and clinical psychologist, co-edited a special issue in the journal Health Psychology.
Late-Breaking Basic Science submissions for the AHA Scientific Sessions close August 23.
Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, provides a mechanism to identify abnormalities linked with hypertrophic cardiomyopathy.
The Heart Rhythm Society annual meeting will be held in San Francisco, CA, from Friday, April 29 - Sunday, May 1, 2022.
Dr. Jeptha P. Curtis has accepted the role of Medical Director of the Yale New Haven Hospital Cardiac Catheterization Laboratories and Director, Coronary Interventions for the Yale New Haven Health System.
The Section of Cardiovascular Medicine is pleased to announce the launch of a distinguished lectureship series honoring the Giants of Yale Cardiovascular Medicine.
Arya Mani MD, and colleagues have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes.
Tariq Ahmad MD, MPH, will be presenting at the American Heart Association Scientific Sessions late-breaking science session on Sunday, November 14.